AB Science is currently developing two main compounds, masitinib, a highly selective tyrosine kinase inhibitor and AB8939.
Bewertung:Pixium Vision develops Bionic Vision Systems utilizing its competencies in machine brain interface and artificial intelligence.
Bewertung:IP Informationen
IP: 151.236.54.229